PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
January 14, 2026Open Forum Infectious DiseasesOpen Access

P-356. Preliminary Experience using a Pharmacist-led Intervention to Support Injectable HIV Treatment for Women with Health-related Social Needs

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJ. Harlan MeyerCPCarolina R PriceDTDeShana Tracey

Discussion

Loading...

Member takes

Overview

Pilot program shows benefits of pharmacist support on HIV care in women with health-related social needs, suggesting improved health equity.

Key Points

  • To assess the impact of a pharmacist-led intervention on women with health-related social needs initiating injectable HIV treatment.
  • Single-arm pilot study with women enrolled from an HIV clinic
  • Participants screened for specific criteria related to HIV and social needs
  • Pharmacist provided education, clinical eligibility evaluation, and treatment initiation support
  • Enrolled 25 HIV-positive women with health-related social needs
  • Mean CD4 count of participants was 651 cells/µL
  • Majority reported food insecurity (60%) and substance use issues (72%)

Cite This Study

Meyer et al. (2026) studied this question.

synapsesocial.com/papers/6966f32713bf7a6f02c00defhttps://doi.org/10.1093/ofid/ofaf695.574
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Optimizing the patient journey: Insights from early implementation of long‐acting cabotegravir and rilpivirine in four urban Ryan White‐funded clinics in the United States2026 · 1 citations
  2. 2P-366. Clinical Experience of Long-Acting Cabotegravir/Rilpivirine in an Underserved Population in Houston, Texas2026
  3. 3Implementation of a Pharmacist-Led, Long-Acting, Injectable Cabotegravir/Rilpivirine Program for HIV-1 at Health System-Based Clinics in the New York Metropolitan Area2024 · 22 citations
  4. 4Analysis of a clinical pathway for the use of long-acting injectable antiretroviral therapy in adherence challenged people living with HIV2026
  5. 5Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South2024 · 16 citations